Hepatitis B Therapeutics Market
1 Study Coverage
1.1 Hepatitis B Therapeutics Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Hepatitis B Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Hepatitis B Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Hepatitis B Therapeutics Market Size for the Year 2017-2028
1.3 Hepatitis B Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Hepatitis B Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Hepatitis B Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Hepatitis B Therapeutics Market Dynamics
1.4.1 Hepatitis B Therapeutics Industry Trends
1.4.2 Hepatitis B Therapeutics Market Drivers
1.4.3 Hepatitis B Therapeutics Market Challenges
1.4.4 Hepatitis B Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Hepatitis B Therapeutics by Type
2.1 Hepatitis B Therapeutics Market Segment by Type
2.1.1 Hepatitis B Vaccine
2.1.2 Anti-viral Drugs
2.2 Global Hepatitis B Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Hepatitis B Therapeutics Market Size by Type (2017-2028)
2.4 United States Hepatitis B Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Hepatitis B Therapeutics Market Size by Type (2017-2028)
3 Hepatitis B Therapeutics by Application
3.1 Hepatitis B Therapeutics Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Hepatitis B Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Hepatitis B Therapeutics Market Size by Application (2017-2028)
3.4 United States Hepatitis B Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Hepatitis B Therapeutics Market Size by Application (2017-2028)
4 Global Hepatitis B Therapeutics Competitor Landscape by Company
4.1 Global Hepatitis B Therapeutics Market Size by Company
4.1.1 Top Global Hepatitis B Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Hepatitis B Therapeutics Revenue by Player (2017-2022)
4.2 Global Hepatitis B Therapeutics Concentration Ratio (CR)
4.2.1 Hepatitis B Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Hepatitis B Therapeutics in 2021
4.2.3 Global Hepatitis B Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Hepatitis B Therapeutics Headquarters, Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Hepatitis B Therapeutics Headquarters and Area Served
4.3.2 Global Hepatitis B Therapeutics Companies Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Hepatitis B Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Hepatitis B Therapeutics Market Size by Company
4.5.1 Top Hepatitis B Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Hepatitis B Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Hepatitis B Therapeutics Market Size by Region
5.1 Global Hepatitis B Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Hepatitis B Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Hepatitis B Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Hepatitis B Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Hepatitis B Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Hepatitis B Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Hepatitis B Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Hepatitis B Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Hepatitis B Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Hepatitis B Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Hepatitis B Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Hepatitis B Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Hepatitis B Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Hepatitis B Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Details
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Hepatitis B Therapeutics Introduction
7.1.4 GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2017-2022)
7.1.5 GlaxoSmithKline Recent Development
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Details
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Hepatitis B Therapeutics Introduction
7.2.4 Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2017-2022)
7.2.5 Bristol-Myers Squibb Recent Development
7.3 Novira Therapeutics
7.3.1 Novira Therapeutics Company Details
7.3.2 Novira Therapeutics Business Overview
7.3.3 Novira Therapeutics Hepatitis B Therapeutics Introduction
7.3.4 Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2017-2022)
7.3.5 Novira Therapeutics Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Details
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Hepatitis B Therapeutics Introduction
7.4.4 Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2017-2022)
7.4.5 Johnson & Johnson Recent Development
7.5 Abivax
7.5.1 Abivax Company Details
7.5.2 Abivax Business Overview
7.5.3 Abivax Hepatitis B Therapeutics Introduction
7.5.4 Abivax Revenue in Hepatitis B Therapeutics Business (2017-2022)
7.5.5 Abivax Recent Development
7.6 F. Hoffmann- La Roche
7.6.1 F. Hoffmann- La Roche Company Details
7.6.2 F. Hoffmann- La Roche Business Overview
7.6.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Introduction
7.6.4 F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2017-2022)
7.6.5 F. Hoffmann- La Roche Recent Development
7.7 Novartis
7.7.1 Novartis Company Details
7.7.2 Novartis Business Overview
7.7.3 Novartis Hepatitis B Therapeutics Introduction
7.7.4 Novartis Revenue in Hepatitis B Therapeutics Business (2017-2022)
7.7.5 Novartis Recent Development
7.8 Merck
7.8.1 Merck Company Details
7.8.2 Merck Business Overview
7.8.3 Merck Hepatitis B Therapeutics Introduction
7.8.4 Merck Revenue in Hepatitis B Therapeutics Business (2017-2022)
7.8.5 Merck Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Hepatitis B Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Hepatitis B Therapeutics Market Trends
Table 3. Hepatitis B Therapeutics Market Drivers
Table 4. Hepatitis B Therapeutics Market Challenges
Table 5. Hepatitis B Therapeutics Market Restraints
Table 6. Global Hepatitis B Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Hepatitis B Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Hepatitis B Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Hepatitis B Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Hepatitis B Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Hepatitis B Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Hepatitis B Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Hepatitis B Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis B Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Therapeutics as of 2021)
Table 15. Top Players of Hepatitis B Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Hepatitis B Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Hepatitis B Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Hepatitis B Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Hepatitis B Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Hepatitis B Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Hepatitis B Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Hepatitis B Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Hepatitis B Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Hepatitis B Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Hepatitis B Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Hepatitis B Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Hepatitis B Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. GlaxoSmithKline Company Details
Table 31. GlaxoSmithKline Business Overview
Table 32. GlaxoSmithKline Hepatitis B Therapeutics Product
Table 33. GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
Table 34. GlaxoSmithKline Recent Development
Table 35. Bristol-Myers Squibb Company Details
Table 36. Bristol-Myers Squibb Business Overview
Table 37. Bristol-Myers Squibb Hepatitis B Therapeutics Product
Table 38. Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
Table 39. Bristol-Myers Squibb Recent Development
Table 40. Novira Therapeutics Company Details
Table 41. Novira Therapeutics Business Overview
Table 42. Novira Therapeutics Hepatitis B Therapeutics Product
Table 43. Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Novira Therapeutics Recent Development
Table 45. Johnson & Johnson Company Details
Table 46. Johnson & Johnson Business Overview
Table 47. Johnson & Johnson Hepatitis B Therapeutics Product
Table 48. Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Johnson & Johnson Recent Development
Table 50. Abivax Company Details
Table 51. Abivax Business Overview
Table 52. Abivax Hepatitis B Therapeutics Product
Table 53. Abivax Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Abivax Recent Development
Table 55. F. Hoffmann- La Roche Company Details
Table 56. F. Hoffmann- La Roche Business Overview
Table 57. F. Hoffmann- La Roche Hepatitis B Therapeutics Product
Table 58. F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
Table 59. F. Hoffmann- La Roche Recent Development
Table 60. Novartis Company Details
Table 61. Novartis Business Overview
Table 62. Novartis Hepatitis B Therapeutics Product
Table 63. Novartis Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Merck Company Details
Table 66. Merck Business Overview
Table 67. Merck Hepatitis B Therapeutics Product
Table 68. Merck Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Merck Recent Development
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis B Therapeutics Product Picture
Figure 2. Global Hepatitis B Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Hepatitis B Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Hepatitis B Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Hepatitis B Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Hepatitis B Therapeutics Market Share in Global 2017-2028
Figure 7. Hepatitis B Therapeutics Report Years Considered
Figure 8. Product Picture of Hepatitis B Vaccine
Figure 9. Product Picture of Anti-viral Drugs
Figure 10. Global Hepatitis B Therapeutics Market Share by Type in 2022 & 2028
Figure 11. Global Hepatitis B Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Hepatitis B Therapeutics Market Share by Type (2017-2028)
Figure 13. United States Hepatitis B Therapeutics Market Share by Type in 2022 & 2028
Figure 14. United States Hepatitis B Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Hepatitis B Therapeutics Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospital Pharmacies
Figure 17. Product Picture of Retail Pharmacies
Figure 18. Product Picture of Online Pharmacies
Figure 19. Global Hepatitis B Therapeutics Market Share by Application in 2022 & 2028
Figure 20. Global Hepatitis B Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Hepatitis B Therapeutics Market Share by Application (2017-2028)
Figure 22. United States Hepatitis B Therapeutics Market Share by Application in 2022 & 2028
Figure 23. United States Hepatitis B Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Hepatitis B Therapeutics Market Share by Application (2017-2028)
Figure 25. North America Hepatitis B Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Hepatitis B Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Hepatitis B Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Hepatitis B Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Hepatitis B Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.A.E Hepatitis B Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
Figure 55. Novira Therapeutics Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
Figure 56. Johnson & Johnson Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
Figure 57. Abivax Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
Figure 58. F. Hoffmann- La Roche Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
Figure 59. Novartis Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
Figure 60. Merck Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Industry Market Size
